After gastric bypass surgery, important to check vitamin B1 deficiency

December 26, 2005

A deficiency in vitamin B1 can be a serious complication following a popular surgery to treat obesity, according to a case study published in the December 27, 2005 issue of Neurology, the scientific journal of the American Academy of Neurology. If untreated, vitamin B1 deficiency can lead to Wernicke encephalopathy, a severe neurological condition.

In the study, a 35-year-old woman developed many difficulties after gastric bypass (bariatric) surgery for obesity. Difficulties included nausea, anorexia, fatigue, hearing loss, forgetfulness, and ataxia, or an inability to coordinate muscle movements. By the 12th week following surgery, she had lost 40 pounds and had difficulty walking and concentrating.

"This case highlights the variability of Wernicke encephalopathy where the classic trio of eye movement abnormalities, confusion, and ataxia are seen in less than 20 percent of patients," said Heidi Schwarz, MD, who wrote a related commentary. "It is unusual because the patient also had hearing loss."

An MRI scan showed abnormal signals in various parts of the woman's brain, indicating a deficiency in vitamin B1. Also known as thiamine, vitamin B1 is essential for carbohydrate metabolism and normal functioning of the nervous system. When her intravenous dose of vitamin B1 was increased to 100 mg every eight hours, her eye muscles gradually returned to normal and her confusion decreased.

Eleven days after her dose of vitamin B1 was increased, a follow-up MRI scan showed the abnormal signals had decreased. The scan also indicated spots in the premotor and motor regions due to hemorrhaging, which is another sign of Wernicke encephalopathy.

"The neurological complications following gastric bypass surgery are diverse," said co-author Raul N. Mandler, MD, a Fellow of the American Academy of Neurology and neurologist at The George Washington University in Washington, D.C. "Vitamin B1 deficiency and Wernicke encephalopathy should be carefully considered in surgically treated obese patients."
-end-
The American Academy of Neurology, an association of nearly 19,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington's disease, and dementia. For more information about the American Academy of Neurology, visit www.aan.com.

American Academy of Neurology

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.